Application no. and date | 11701735.0 (espacenet) (Federated) (European Patent Register), 20110128 | Patent/reg. no. and date | DK/EP 2528945, 20161026 | Publication date | 20121205 | Priority no. and date | US 299801 P, 20100129, US 361687 P, 20100706, US 388697 P, 20101001 | EP pub. no. and date |
EP 2528945 20121205 | Effective date | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road Tarrytown, NY 10591, US | Applicant ref. no. | P019051EPDK1 JOS/Ve | Inventor | SKOKOS, Dimitris, c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | C07K 16/22 (2006.01) | Title | FREMGANGSMÅDER TIL BEHANDLING AF DIABETES MED DLL4-ANTAGONISTER | Int. application no. | US2011022817 | Int. publication no. | WO2011094467 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|